CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial

M.P. Saunders,J. Graham,D. Cunningham, R. Plummer,D. Church,R. Kerr, S. Cook, S. Zheng,N. La Thangue,D. Kerr

ESMO Open（2022）

引用 2|浏览12

暂无评分

摘要

The primary endpoint was met in this phase II study, which showed that the combination of CXD101 and nivolumab, at full individual doses in the treatment of advanced or metastatic MSS CRC, was both well tolerated and efficacious.

查看译文

关键词

CXD101,MSS,colorectal cancer,nivolumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要